Use of Novel Antithrombotic Therapies for Patients With Atrial Fibrillation and Bioprosthetic Valves

Circ J. 2022 Feb 25;86(3):425-426. doi: 10.1253/circj.CJ-21-1029. Epub 2022 Jan 28.

Authors

Yusuke Kondo¹, Yoshio Kobayashi¹

Affiliation

¹ Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine.

PMID: 35095088
DOI: 10.1253/circj.CJ-21-1029

No abstract available

Publication types

Editorial
Comment

MeSH terms

Atrial Fibrillation* / drug therapy
Bioprosthesis* / adverse effects
Fibrinolytic Agents / adverse effects
Heart Valve Prosthesis*
Humans

Substances

Fibrinolytic Agents